RE:Shorting pharma
I think you've nailed it. Is the "the noise around the possibility of fraudulent practices" from credible places or just from professional bashers/shorters/private equity?
I get reports from RBC Market Research with the Analyst doign weekly scripts reviews, shouldn't they be addressing these bigger questions instead.